Some people cannot tolerate the gastrointestinal effects of GLP-1 medications despite gradual titration and supportive measures
It was marketed as Byetta (produced by Eli Lilly & Amylin Pharmaceuticals)
Be sure to focus on how your body is reacting to the medication and speak to a clinician if youre ever unsure about anything
Godau J, Herfurth M, Kattner B, Gasser T, Berg D
Results Patient Disposition and Baseline Characteristics In total, 2836 patients receiving oral semaglutide 14 mg/flexibly dosed or comparators were included in the background medication subgroup analyses, and 365 patients receiving oral semaglutide 14 mg or placebo in PIONEER 8 were included in the insulin regimen subgroup analysis
Several factors predict who will experience early, intense side effects and who will have a smoother transition